Clinical Trial Update: VA vs DA for Newly Diagnosed Hig-risk AML [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing VA versus DA for newly diagnosed high-risk acute myeloid leukemia is in Phase 2 and Phase 3 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia | Phase 2, Phase 3 | Status: RECRUITING